butyrolactone I

20 Article(s)
Pub. Date
#Total Relationship(s)
1 7574801 [Cell cycle regulation by anticancer agent]. Gan To Kagaku Ryoho 1995 Oct 2
2 7592534 Evidence for cdk5 as a major activity phosphorylating tau protein in porcine brain extract. J Biochem 1995 Apr 2
3 8058318 A cyclin-dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression. Oncogene 1994 Sep 4
4 8395680 Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase. Oncogene 1993 Sep 2
5 8910474 Transcriptional activation of the cdc2 gene is associated with Fas-induced apoptosis of human hematopoietic cells. J Biol Chem 1996 Nov 8 1
6 9042196 Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines. Anticancer Res 1996 Nov-Dec 2
7 9371520 The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res 1997 Nov 15 1
8 9438384 Cdc2-mediated phosphorylation of the gap junction protein, connexin43, during mitosis. Cell Growth Differ 1998 Jan 2
9 9664116 Cdk2/cdc2 expression in colon carcinogenesis and effects of cdk2/cdc2 inhibitor in colon cancer cells. Int J Oncol 1998 Aug 1
10 9703910 An exogenous cdk inhibitor, butyrolactone-I, induces apoptosis with increased Bax/Bcl-2 ratio in p53-mutated pancreatic cancer cells. Anticancer Res 1998 Jul-Aug 8
11 9891485 Suppression of albumin and alpha-fetoprotein gene expression by butyrolactone I, a selective inhibitor of the cdk family, in HuH-7 human hepatoma cells. Anticancer Res 1998 Nov-Dec 2
12 10079191 Neuronal differentiation of neuro 2a cells by inhibitors of cell cycle progression, trichostatin A and butyrolactone I. Biochem Biophys Res Commun 1999 Mar 16 2
13 11423970 Activation of p53 by roscovitine-mediated suppression of MDM2 expression. Oncogene 2001 May 31 3
14 11882652 Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protection. J Biol Chem 2002 May 17 4
15 15123618 Involvement of Cdk5/p25 in digoxin-triggered prostate cancer cell apoptosis. J Biol Chem 2004 Jul 9 1
16 16291822 Estradiol-17beta stimulates proliferation of mouse embryonic stem cells: involvement of MAPKs and CDKs as well as protooncogenes. Am J Physiol Cell Physiol 2006 Apr 1
17 29763312 Deep-Sea-Derived Butyrolactone I Suppresses Ovalbumin-Induced Anaphylaxis by Regulating Mast Cell Function in a Murine Model. J Agric Food Chem 2018 Jun 6 1
18 31450982 Butyrolactone-I, an efficient α-glucosidase inhibitor, improves type 2 diabetes with potent TNF-α-lowering properties through modulating gut microbiota in db/db mice. FASEB J 2019 Nov 2
19 32054125 Cyclin-Dependent Kinase 5 Inhibitor Butyrolactone I Elicits a Partial Agonist Activity of Peroxisome Proliferator-Activated Receptor γ. Biomolecules 2020 Feb 11 7
20 34660669 Coral-Derived Endophytic Fungal Product, Butyrolactone-I, Alleviates Lps Induced Intestinal Epithelial Cell Inflammatory Response Through TLR4/NF-κB and MAPK Signaling Pathways: An <i>in vitro</i> and <i>in vivo</i> Studies. Front Nutr 2021 4